Amicus Therapeutics (FOLD) Long-Term Debt Repayments (2016 - 2018)
Historic Long-Term Debt Repayments for Amicus Therapeutics (FOLD) over the last 9 years, with Q4 2018 value amounting to -$218000.0.
- Amicus Therapeutics' Long-Term Debt Repayments fell 32708.33% to -$218000.0 in Q4 2018 from the same period last year, while for Dec 2021 it was -$218000.0, marking a year-over-year decrease of 5352.11%. This contributed to the annual value of $408.0 million for FY2023, which is N/A changed from last year.
- As of Q4 2018, Amicus Therapeutics' Long-Term Debt Repayments stood at -$218000.0, which was down 32708.33% from $76000.0 recorded in Q3 2018.
- Amicus Therapeutics' Long-Term Debt Repayments' 5-year high stood at $5.6 million during Q1 2014, with a 5-year trough of -$218000.0 in Q4 2018.
- In the last 4 years, Amicus Therapeutics' Long-Term Debt Repayments had a median value of $71000.0 in 2016 and averaged $549181.8.
- Per our database at Business Quant, Amicus Therapeutics' Long-Term Debt Repayments soared by 2800.0% in 2017 and then plummeted by 32708.33% in 2018.
- Over the past 4 years, Amicus Therapeutics' Long-Term Debt Repayments (Quarter) stood at $5.6 million in 2014, then crashed by 98.66% to $75000.0 in 2016, then increased by 28.0% to $96000.0 in 2017, then plummeted by 327.08% to -$218000.0 in 2018.
- Its last three reported values are -$218000.0 in Q4 2018, $76000.0 for Q3 2018, and $71000.0 during Q2 2018.